Wenfeng Great World Chain Development Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 0/6

Anahtar bilgiler

1.5%

Borç/özkaynak oranı

CN¥64.83m

Borç

Faiz karşılama oranı	-26.3x
Nakit	CN¥850.19m
Eşitlik	CN¥4.34b
Toplam yükümlülükler	CN¥1.93b
Toplam varlıklar	CN¥6.27b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Wenfeng Great World Chain Development's (SHSE:601010) Solid Earnings Have Been Accounted For Conservatively

May 06

Wenfeng Great World Chain Development Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 0/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Third quarter 2024 earnings released: CN¥0.002 loss per share (vs CN¥0.001 profit in 3Q 2023)

Wenfeng Great World Chain Development Corporation to Report Q3, 2024 Results on Oct 31, 2024

Investor sentiment improves as stock rises 22%

Second quarter 2024 earnings released: EPS: CN¥0.01 (vs CN¥0.02 in 2Q 2023)

Wenfeng Great World Chain Development Corporation to Report First Half, 2024 Results on Aug 10, 2024

Wenfeng Great World Chain Development's (SHSE:601010) Solid Earnings Have Been Accounted For Conservatively

Wenfeng Great World Chain Development Corporation, Annual General Meeting, May 20, 2024

First quarter 2024 earnings released: EPS: CN¥0.03 (vs CN¥0.05 in 1Q 2023)

Wenfeng Great World Chain Development Corporation to Report Q1, 2024 Results on Apr 30, 2024

Investor sentiment deteriorates as stock falls 18%

Wenfeng Great World Chain Development Corporation to Report Fiscal Year 2023 Results on Apr 30, 2024

Wenfeng Great World Chain Development Corporation to Report Q3, 2023 Results on Oct 31, 2023

Second quarter 2023 earnings released: EPS: CN¥0.02 (vs CN¥0.11 loss in 2Q 2022)

Wenfeng Great World Chain Development Corporation to Report First Half, 2023 Results on Aug 29, 2023

Genesis Medtech Investment (HK) Limited intends to acquire remaining 30.4348% stake in Nantong Horcon Medical Technology Co.,Ltd. from Wenfeng Great World Chain Development Corporation (SHSE:601010) for CNY 57.4 million.

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.01 (vs CN¥0.019 loss in 3Q 2021)

Second quarter 2022 earnings released: CN¥0.11 loss per share (vs CN¥0.079 profit in 2Q 2021)

First quarter 2022 earnings released: CN¥0.01 loss per share (vs CN¥0.046 profit in 1Q 2021)

Third quarter 2021 earnings released: CN¥0.019 loss per share (vs CN¥0.02 profit in 3Q 2020)

Wenfeng Great World Chain Development Corporation (SHSE:601010) announces an Equity Buyback for CNY 100 million worth of its shares.

Second quarter 2021 earnings released: EPS CN¥0.079 (vs CN¥0.049 in 2Q 2020)

Full year 2020 earnings released: EPS CN¥0.15 (vs CN¥0.18 in FY 2019)

New 90-day low: CN¥2.83

New 90-day low: CN¥2.90

New 90-day low: CN¥3.03

Third quarter 2020 earnings released: EPS CN¥0.02

Wenfeng Great World Chain Development Corporation to Report Q3, 2020 Results on Oct 31, 2020

New 90-day low: CN¥3.15

Wenfeng Great World Chain Development Corporation Approves Board and Executive Appointments

Wenfeng Great World Chain Development Corporation to Report First Half, 2020 Results on Aug 29, 2020

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin